Levels of interleukin-1 beta can predict response to tocilizumab therapy in rheumatoid arthritis: the PETITE (predictors of effectiveness of tocilizumab therapy) study.
about
Levels of interleukin-1 beta can predict response to tocilizumab therapy in rheumatoid arthritis: the PETITE (predictors of effectiveness of tocilizumab therapy) study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Levels of interleukin-1 beta c ...... of tocilizumab therapy) study.
@en
Levels of interleukin-1 beta c ...... eumatoid arthritis: the PETITE
@nl
type
label
Levels of interleukin-1 beta c ...... of tocilizumab therapy) study.
@en
Levels of interleukin-1 beta c ...... eumatoid arthritis: the PETITE
@nl
prefLabel
Levels of interleukin-1 beta c ...... of tocilizumab therapy) study.
@en
Levels of interleukin-1 beta c ...... eumatoid arthritis: the PETITE
@nl
P2093
P2860
P1476
Levels of interleukin-1 beta c ...... of tocilizumab therapy) study.
@en
P2093
Hiroaki Nakamura
Kenji Mamoto
Kentaro Inui
Masahiro Tada
Shigeyuki Wakitani
Tadashi Okano
Tatsuya Koike
Yuko Sugioka
P2860
P2888
P304
P356
10.1007/S00296-015-3379-X
P577
2015-10-05T00:00:00Z